Ireland vs Norway: Cause of death, by non-communicable diseases, ages 5-14, male
Ireland
70.7%
in 2021
Norway
69.1%
in 2021
Ireland rank
11th
Norway rank
13th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Ireland
- Norway
How they compare
Ireland currently reports 70.7% against 69.1% in Norway, a difference of 1.6%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Norway ahead.
Ireland ranks 11th and Norway ranks 13th of 185 countries.
Across the 3 decades both report, Ireland averaged higher in 1 and Norway in 2.
Head to head by decade
| Decade | Ireland | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 46.8% | 47.4% | 0.7% | Norway |
| 2010s | 73.8% | 65.0% | 8.9% | Ireland |
| 2020s | 66.2% | 67.1% | 0.9% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Ireland or Norway?
- Ireland, at 70.7% against 69.1% in Norway as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Ireland and Norway?
- 1.6%, with Ireland ahead.
- How many years of comparable data are there for Ireland and Norway?
- 6 years are reported by both, from 2000 to 2021.
- How do Ireland and Norway rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Ireland ranks 11th and Norway ranks 13th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.